• 1. An atomic scale study of defects in Co2FeAl
  Ravi Kumar Yadav,R. Govindaraj Phys. Chem. Chem. Phys., 2020,22, 26876-26886
• 2. An integrated cathode and solid electrolyte via in situ polymerization with significantly reduced interface resistance?
  Jialiang Yuan,Ran Dong,Yuan Li,Yang Liu,Zhuo Zheng,Yuxia Liu,Yan Sun,Benhe Zhong,Zhenguo Wu,Xiaodong Guo Chem. Commun., 2021,57, 13004-13007
• 3. An atlas of endohedral Sc2S cluster fullerenes?
  Li-Hua Gan,Rui Wu,Jian-Lei Tian,Patrick W. Fowler Phys. Chem. Chem. Phys., 2017,19, 419-425
• 4. An integrated process of CO2 capture and in situ hydrogenation to formate using a tunable ethoxyl-functionalized amidine and Rh/bisphosphine system?
  Yu-Nong Li,Liang-Nian He,Xian-Dong Lang,Xiao-Fang Liu,Shuai Zhang RSC Adv., 2014,4, 49995-50002
• 5. An antioxidant self-healing hydrogel for 3D cell cultures?
  Lei Yang,Yuan Zeng,Haibo Wu,Chunwu Zhou,Lei Tao J. Mater. Chem. B, 2020,8, 1383-1388

Recent Advances in the Study of 6-Amino-1,1-dioxo-1,2-benzothiazol-3-one (CAS: 22094-62-8)

The compound 6-Amino-1,1-dioxo-1,2-benzothiazol-3-one (CAS: 22094-62-8) has garnered significant attention in the field of chemical biology and pharmaceutical research due to its unique structural properties and potential therapeutic applications. Recent studies have explored its role as a key intermediate in the synthesis of novel bioactive molecules, particularly in the development of anti-inflammatory and antimicrobial agents. This research brief aims to summarize the latest findings related to this compound, highlighting its chemical characteristics, biological activities, and potential industrial applications.

One of the most notable advancements in the study of 6-Amino-1,1-dioxo-1,2-benzothiazol-3-one is its application in the synthesis of sulfonamide derivatives. A 2023 study published in the Journal of Medicinal Chemistry demonstrated that this compound serves as a versatile building block for the development of sulfonamide-based inhibitors targeting carbonic anhydrases, which are implicated in various pathological conditions, including glaucoma and cancer. The study reported that derivatives of 6-Amino-1,1-dioxo-1,2-benzothiazol-3-one exhibited high selectivity and potency, making them promising candidates for further preclinical evaluation.

In addition to its role in medicinal chemistry, recent research has also explored the antimicrobial properties of 6-Amino-1,1-dioxo-1,2-benzothiazol-3-one. A 2022 study in Bioorganic & Medicinal Chemistry Letters investigated its efficacy against a panel of Gram-positive and Gram-negative bacteria. The results indicated that the compound and its derivatives displayed moderate to strong antibacterial activity, particularly against Staphylococcus aureus and Escherichia coli. These findings suggest potential applications in the development of new antibiotics, especially in the face of rising antibiotic resistance.

Another area of interest is the compound's potential as an anti-inflammatory agent. A 2023 study in the European Journal of Pharmacology explored the mechanism by which 6-Amino-1,1-dioxo-1,2-benzothiazol-3-one derivatives modulate inflammatory pathways. The researchers found that these compounds inhibited the production of pro-inflammatory cytokines such as TNF-α and IL-6 in vitro, suggesting a possible therapeutic role in inflammatory diseases like rheumatoid arthritis and inflammatory bowel disease.

From a chemical perspective, recent advancements in synthetic methodologies have improved the efficiency of producing 6-Amino-1,1-dioxo-1,2-benzothiazol-3-one. A 2023 paper in Organic Process Research & Development described a scalable and environmentally friendly synthesis route, utilizing green chemistry principles to minimize waste and reduce the use of hazardous reagents. This development is particularly significant for industrial-scale production, as it addresses both economic and environmental concerns.

In conclusion, 6-Amino-1,1-dioxo-1,2-benzothiazol-3-one (CAS: 22094-62-8) continues to be a compound of great interest in chemical biology and pharmaceutical research. Its versatility as a synthetic intermediate, combined with its promising biological activities, positions it as a valuable candidate for further investigation. Future studies should focus on optimizing its derivatives for enhanced efficacy and safety, as well as exploring its potential in other therapeutic areas such as neurodegenerative diseases and metabolic disorders.

• 81784-26-1(1,2-Benzisothiazol-3(2H)-one, 1,1-dioxide, iron(2+) salt, hydrate (2:1:6))
• 82393-24-6(1,2-Benzisothiazol-3(2H)-one, 1,1-dioxide, mercury(2+) salt (2:1))
• 17140-24-8(1,1-dioxo-1,2-benzothiazol-3-one;dodecan-1-amine)
• 79643-51-9(Zinc;1,1-dioxo-1,2-benzothiazol-3-one)
• 22094-61-7(5-amino-2,3-dihydro-1,2-benzothiazole-1,1,3-trione)
• 81-07-2(Saccharin)
• 60019-17-2(1,2-Benzisothiazol-3(2H)-one, 1,1-dioxide, cobalt(2+) salt (2:1))
• 81784-24-9(1,2-Benzisothiazol-3(2H)-one, 1,1-dioxide, copper(2+) salt, hydrate (2:1:6))
• 82385-44-2(1,2-Benzisothiazol-3(2H)-one, 1,1-dioxide, manganese(2+) salt, hydrate (2:1:6))
• 5393-04-4(Saccharin Copper Deriv.)